AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H1172-H1182, 2007. First published April 27, 2007; doi:10.1152/ajpheart.00279.2007
0363-6135/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/2/H1172    most recent
00279.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pritchard, T. J.
Right arrow Articles by Paul, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pritchard, T. J.
Right arrow Articles by Paul, R. J.

Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure

Tracy J. Pritchard,1 Michelle Parvatiyar,1 Daniel P. Bullard,1 Ronald M. Lynch,2 John N. Lorenz,1 and Richard J. Paul1

1Department of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio; and 2Department of Physiology, University of Arizona Health Sciences Center, Tucson, Arizona

Submitted 6 March 2007 ; accepted in final form 25 April 2007


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The Na+-K+-ATPase (NKA) is a transmembrane protein that sets and maintains the electrochemical gradient by extruding three Na+ in exchange for two K+. An important physiological role proposed for vascular smooth muscle NKA is the regulation of blood pressure via modulation of vascular smooth muscle contractility (5). To investigate the relations between the level of NKA in smooth muscle and blood pressure, we developed mice carrying a transgene for either the NKA {alpha}1- or {alpha}2-isoform ({alpha}1sm+ or {alpha}2sm+ mice) driven by the smooth muscle-specific {alpha}-actin promoter SMP8. Interestingly, both {alpha}-isoforms, the one contained in the transgene and the one not contained, were increased to a similar degree at both protein and mRNA levels. The total {alpha}-isoform protein was increased from 1.5-fold ({alpha}1sm+ mice) to 7-fold ({alpha}2sm+ mice). The increase in total NKA {alpha}-isoform protein was accompanied by a 2.5-fold increase in NKA activity in {alpha}2sm+ gastric antrum. Immunocytochemistry of the {alpha}1- and {alpha}2-isoforms in {alpha}2sm+ aortic smooth muscle cells indicated that {alpha}-isoform distributions were similar to those shown in wild-type cells. {alpha}2sm+ Mice (high expression) were hypotensive (109.9 ± 1.6 vs. 121.3 ± 1.4 mmHg; n = 13 and 11, respectively), whereas {alpha}1sm+ mice (low expression) were normotensive (122.7 ± 2.5 vs. 117.4 ± 2.3; n = 11 or 12). {alpha}2sm+ Aorta, but not {alpha}1sm+ aorta, relaxed faster from a KCl-induced contraction than wild-type aorta. Our results show that smooth muscle displays unique coordinate expression of the {alpha}-isoforms. Increasing smooth muscle NKA decreases blood pressure and is dependent on the degree of increased {alpha}-isoform expression.

vascular contractility; hypertension; Na+-K+-ATPase {alpha}-isoforms


THE Na+-K+-ATPase (NKA) is a transmembrane protein that sets and maintains the electrochemical gradient by extruding three Na+ in exchange for two K+, which underlies numerous Na+-coupled transport processes. An important physiological role proposed for NKA is the regulation of blood pressure via modulation of vascular smooth muscle contractility (5). With hypertension, heart failure, and diabetes, conditions known to have a vascular involvement, cardiac NKA expression has been reported to be changed (18, 32, 34). NKA expression can be induced by insulin, thyroid hormone, and aldosterone (8), hormones whose concentrations are altered in disease states. However, there are limited data regarding smooth muscle-specific changes in NKA expression with disease. Furthermore, diseases are multifactorial, thereby complicating the understanding of changes in smooth muscle phenotypes solely in terms of NKA expression.

In the case of salt-sensitive hypertension, NKA is hypothesized (5, 13) to participate, via modulation of intracellular Ca2+ concentration ([Ca2+]i) and contractility, by coupling to the Na+/Ca2+ exchanger (NCX). A variety of studies have demonstrated that decreases in NKA activity are associated with an elevated blood pressure. These include pharmacological manipulation with cardiac glycosides as well as genetically induced decreases in NKA expression (5, 7, 11). However, to validate causality rather than correlation, gain of function studies are needed to demonstrate whether increases in NKA activity can produce decreases in blood pressure.

NKA is a heterodimer composed of an {alpha}-subunit, responsible for catalytic function, and a beta-subunit (2, 4, 79, 16). In aorta, two ({alpha}1 and {alpha}2) (30) of the four known {alpha}-isoforms (2, 4, 7) are present; 70% of the total NKA is composed of the {alpha}1-isoform and the remaining 30% is the {alpha}2-isoform (30). To investigate a gain of NKA function on blood pressure, we developed mice that carry transgenes for either the NKA {alpha}1- or {alpha}2-isoform, using the smooth muscle-specific {alpha}-actin promoter (6) SMP8. The {alpha}-isoforms in smooth muscle from the {alpha}1sm+ mouse line were increased by ~1.5-fold and up to 7-fold in the {alpha}2sm+ mouse line. An important, but surprising observation was that the {alpha}-isoform not contained in the transgene was upregulated to a similar degree. We show that an increase in NKA {alpha}-isoforms leads to a decreased blood pressure, which is dependent on the degree of increased vascular NKA expression. Thus increased expression of vascular NKA can lead to hypotension and perhaps provides a novel pathway for treatment of hypertension.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Generation of transgenic mice. {alpha}1- or {alpha}2-isoform NKA rat cDNA (gift from Dr. Jerry Lingrel, University of Cincinnati) was inserted via HindIII restriction sites into transfer vector pSAHSK + GSSS (Fig. 1, A and B) containing AscI and SnabI restriction sites (generated by Genomatix, Cincinnati, OH). Resultant clones were screened for cDNA orientation using XbaI and NotI restriction endonucleases for vectors containing the {alpha}1-isoform or EcoRI and NotI enzymes for vectors with the {alpha}2-isoform. The {alpha}1- or {alpha}2-isoform NKA cDNA was then cloned via AscI and SnabI sites into target vector pSMP8 + RPNKAA + human growth hormone poly(A) (generated by Genomatix) containing the {alpha}-actin smooth muscle-specific promoter SMP8 (6) and a human growth hormone polyadenylation sequence (Fig. 1C). Proper construction of the transgenes was verified by sequencing the 5' and 3' ends of the cDNA using primers targeted to the plasmid at the 3' end of the promoter (5'-GTGTTAGTTGAGAACTGTGG-3') and the 5' end of the polyadenylation sequence (5'-GAAGGACACCTAGTCAGACA-3'). Sequencing was performed by the University of Cincinnati DNA Core. The {alpha}1- or {alpha}2-isoform transgenes were linearized (Fig. 1D) via two NotI sites, purified, and microinjected into the pronucleus of fertilized mouse eggs (FVB/n) that were then implanted into pseudopregnant females by the University of Cincinnati Transgenic Mouse Core (Cincinnati, OH). Resultant founder mice produced from this procedure were identified by PCR and Southern blot analyses and then subsequently bred to wild-type (WT) FVB/n mice.


Figure 1
View larger version (9K):
[in this window]
[in a new window]

 
Fig. 1. Linear map of the Na+-K+-ATPase (NKA) {alpha}-isoform transgenes. HindIII-bound NKA {alpha}1- or {alpha}2-isoform rat cDNAs (A) were cloned into transfer vector pSAHSK + GSSS (Genomatix) (B). The {alpha}-isoform cDNA was then inserted into target vector pSMP8 + RPNKAA + human growth hormone (hGH) poly(A) (Genomatix) via AscI and SnabI sites (C). The transgene was released at NotI sites for pronuclear microinjection (D).

 
Animal use and tissue preparation. The treatment of animals followed experimental protocols that were approved by the University of Cincinnati and University of Arizona Institutional Animal Care and Use Committees. Animals were given normal rodent chow (Harlan Teklad, Madison, WI) and water ad libitum. All animals used in the subsequent experiments were gender-matched littermate pairs of 12–15 wk old. Adult mice were euthanized in a precharged CO2 chamber followed by immediate removal of thoracic aorta, gastric antrum (lower portion of the stomach), and heart. Tissues were dissected and rinsed with cold physiological saline solution (PSS; in mM: 118 NaCl, 4.7 KCl, 25 NaHCO3, 2.5 CaCl2, 1.2 MgSO4, 1.2 NaH2PO4, 0.026 EDTA, and 11 glucose).

Genotyping of transgenic mice. Founder mice and subsequent transgenic offspring were identified by PCR. DNA from tail biopsies (~1 cm) was isolated using ethanol precipitation. Primers targeting the 5' end of the {alpha}1-isoform cDNA (5'-ATGTCCCTTTCCTTCTTCGC-3') and the 3' end of the SMP8 promoter (5'-GGATCATCAAAGGCTTTACAGC-3') or the 5' end of the human growth hormone poly(A) tail (5'-CAGGTTGTCTTCCCAACTTG-3') and the 3' end of the {alpha}2-isoform cDNA (5'-GGGTGGAGAAGGAGACGTAC-3') were generated for PCR analysis of {alpha}1sm+ and {alpha}2sm+ mice, respectively. PCR conditions included denaturation at 94°C for 3 min, 30 cycles at 94°C for 1 min, 57°C for 1 min, 72°C for 1 min, and elongation at 72°C for 10 min. PCR products were electrophoresed on 1% agarose gels containing ethidium bromide for visualization.

Southern blot analysis. For Southern blot, tail DNA (extracted the same as for genotyping) was digested with HindIII restriction enzyme and separated on a 1% agarose gel. DNA was transferred to a nylon membrane and probed with a random primed 32P-labeled (random primer DNA labeling kit; Invitrogen, Carlsbad, CA) 1,360-bp fragment of the {alpha}1-isoform cDNA (isolated using BamHI and XbaI restriction enzymes) or 1,965-bp fragment of the {alpha}2-isoform cDNA (isolated using BamHI and EcoRI restriction enzymes). The probes hybridized to a 4-kb product of the HindIII-digested tail DNA.

Western blot analysis. Aorta was dissected free from connective tissue and fat, and the endothelium was removed. Gastric antrum was rinsed free of digestive debris, and the mucosa was removed. Hearts were removed of any fat and connective tissue and rinsed thoroughly of blood. Tissues were frozen in liquid N2. Aorta was homogenized with a dental amalgamator (Caulk, Milford, DE) and antrum and heart with a PowerGen 125 homogenizer (Fisher Scientific, Pittsburgh, PA) in buffer containing 50 mM Tris·HCl, 1% Triton X-100, 0.5% deoxycholic acid, 0.1% SDS, 500 mM NaCl, and 10 mM MgCl2. The homogenization buffer was supplemented with the following inhibitors used at 1:100: phosphatase inhibitor cocktails I and II and protease inhibitor cocktail (Sigma, St. Louis, MO). Protein homogenates were then assayed to determine concentration, with BSA used as a standard (Bio-Rad protein assay, Hercules, CA).

Protein from aorta (10–40 µg) and protein from antrum or heart (2.5–20 µg) were incubated at 37°C for 30 min in Laemmli buffer supplemented with 5% beta-mercaptoethanol followed by separation by SDS-PAGE (Genemate 4–20% express gels; ISC BioExpress, Kaysville, UT) at 100 V for 3 h and then electrotransferred at 220 mA to polyvinylidene difluoride membranes (Millipore, Bedford, MA) overnight at 4°C. The membranes were incubated in 1% blocking reagent (Roche Diagnostics, Indianapolis, IN) in TBST (50 mM Tris·HCl, pH 7.4, 150 mM NaCl, and 0.05% Tween 20) for 1 h at room temperature. Blots were then incubated with monoclonal anti-{alpha}1-antibody that binds to the NH2 terminus of the {alpha}1-isoform ({alpha}6F; Developmental Studies Hybridoma Bank, University of Iowa), polyclonal anti-{alpha}2-antibody that recognizes an intracellular loop region of the {alpha}2-isoform [affinity purified from {alpha}2-antisera using the synthetic HERED peptide (gift from Dr. Thomas Pressley)] (26), or polyclonal KETYY antibody that recognizes the COOH terminus of NKA {alpha}-isoforms (kindly provided by Dr. Jack Kyte) in TBST for 1.5 h at room temperature. Equal loading was verified with the monoclonal anti-actin C4 antibody (gift from Dr. James Lessard) or Ponceau S staining of the actin band. Peroxidase-conjugated goat anti-mouse (Bio-Rad) or anti-rabbit (Calbiochem, La Jolla, CA) secondary antibodies were used.

Blots were developed with an enhanced chemiluminescence kit (Amersham Biosciences, Piscataway, NJ) and exposed with Blue Basic autorad film (ISC BioExpress). Multiple exposures were taken to ensure linearity of the signal. Relative protein expression in transgenic mice compared with paired WT mice was quantitated by densitometry using ImageQuant 5.2 software (Molecular Dynamics, Amersham Biosciences). All summarized results consist of data from at least two Western blots representing two different protein samples. For each genotype, antrum from an average of three mice and aorta from an average of seven mice were pooled for each sample.

Quantitative real-time PCR. Mouse antrum was dissected in ice-cold PSS and rinsed of all debris; the tissue was immediately frozen in liquid N2. Total RNA was isolated using Tri Reagent (Molecular Research Center, Cincinnati, OH) according to manufacturer's instructions. Total RNA concentration and purity were measured spectrophotometrically. Total RNA (2 µg for each sample) was treated with RQ1 RNase-free DNase I (Promega, Madison, WI) before cDNA synthesis. cDNA synthesis was performed with random hexamer primers using the SuperScript III first-strand synthesis system (Invitrogen). cDNA was used in real-time PCR reactions to quantitate relative mRNA levels of the NKA {alpha}-isoforms using published primer sequences for the {alpha}1- and {alpha}2-isoforms (22) and GAPDH as an internal control (12). iQ SYBR green Supermix (Bio-Rad) was used for real-time PCR reactions according to manufacturer's instructions. Reactions were run for 50 cycles at 95°C for 15 s, 58°C for 30 s, and 72°C for 30 s using the iCycler real-time PCR machine and iCycler software (Bio-Rad). cDNA reactions in which reverse transcriptase was omitted were used as negative controls. Threshold cycles (automatically calculated by iCycler software) for GAPDH mRNA were compared between transgenic and paired WT samples for normalization. Each antrum sample was assayed in triplicate, and each real-time PCR reaction was performed at least twice per sample. Three paired antrum samples per transgenic line were used in the analysis. Relative {alpha}-isoform expression (in fold) in transgenic lines compared with paired WT mice was calculated using the delta-delta threshold cycle method (25).

Western blot analysis of the NKA beta-subunits. Gastric antrum from {alpha}1sm+, {alpha}2sm+, and paired WT mice were isolated and homogenized as described in Western blot analysis above. Crude protein homogenates remained either untreated or denatured and digested with glycosidase peptide N-glycosidase F (New England Biolabs, Beverly, MA) according to manufacturer's instructions. Protein samples were resolved by SDS-PAGE and transferred to polyvinylidene difluoride membranes as described in Western blot analysis above. Blots were probed with the polyclonal anti-beta1- or anti-beta2-antibodies spETB1 or spETB2 (kindly provided by Dr. Pablo Martin-Vasallo). Three different antrum samples per genotype were used for analysis where each sample contained three pooled antrum. Relative NKA beta-isoform protein quantitation was performed as described in Western blot analysis above.

Fluorescent, enzyme-linked measurements of NKA activity. Gastric antrum from {alpha}1sm+, {alpha}2sm+, and paired WT mice were dissected and homogenized as described in Western blot analysis above, with the exception of the homogenization buffer. The homogenization buffer contained 0.25 M sucrose, 30 mM imidazole, and 1 mM Na+-free EDTA and was not supplemented with any protease or phosphatase inhibitors.

NKA activities were determined with an enzyme-linked assay measuring the rate of ADP production as linked to the rate of NADH fluorescence decrease in the absence or presence of 1 mM ouabain. Crude protein (50 µg) was incubated for 20 min at 37°C in solution with pH 7.4 containing 100 mM NaCl, 20 mM KCl, 8 mM MgCl2, 40 mM Tris, 1 mM EGTA, 1 mM Na+ azide, 25 mM choline chloride, 1 U/ml lactate dehydrogenase, 1 U/ml pyruvate kinase, 1 mM phosphoenolpyruvate, and 80 µM NADH. The reaction was initiated with the addition of 1 mM ATP. NADH fluorescence was continuously followed (excitation = 340 nm, emission = 460 nm) for 20 min with the use of a spectrofluorometer (PTI Delta Scan-1; Photon Technology International, South Brunswick, NJ). Rates were calculated as nanomoles ATP hydrolyzed per minute per milligram of protein. Three {alpha}1sm+ or {alpha}2sm+ and their paired WT antrum samples were used in the NKA activity measurements, where each protein sample consisted of three pooled antrum. NKA activity was measured for each sample at least twice.

Aorta and cell isolation. Adult mice were euthanized in a precharged CO2 chamber followed by removal of the entire thoracic aorta (exposed from aortic arch to diaphragm). The aorta was dissected free from all associated fatty tissue and removed by cutting the intercostal arteries. Blood was immediately flushed from the isolated vessel with PBS + 0.1% BSA. To produce cell cultures, aortae were incubated in a PBS solution containing collagenase B (6 mg/ml) and BSA (6 mg/ml) and then incubated at 37°C for 40 min. Cells were dispersed from the digested aorta by trituration, diluted in PBS, and centrifuged at ~1,000 g for 3 min. The cell pellet was suspended in 250 µl of DMEM supplemented with 5% FBS and 1% penicillin-streptomycin. Cell suspension from one aorta (250 µl) was plated as 50-µl aliquots onto the center of six glass coverslips housed in individual wells of a six-well plate. The six-well plate was then placed into a 37°C incubator equilibrated with 5% CO2. After ~16 h, 5 ml of fresh DMEM were added to each well. The PBS contained (in mM) 2.7 KCl, 1.5 KH2PO4, 138 NaCl, and 8 Na2HPO4, at pH 7.2.

Immunocytochemistry. At least 96 h after isolation, cells on coverslips were fixed with 3% paraformaldehyde, rinsed with 25 mM glycine, and permeabilized with 0.1% Triton X-100 (17). The cells were incubated with rabbit polyclonal antibody raised against the NKA {alpha}2-isoform (26) for 2 h at 25°C. For {alpha}1-isoform labeling, cells were incubated with the {alpha}1-isoform-specific antibody NASE (26) for 12 h. After labeling with {alpha}-isoform-specific antibodies was completed, cells were washed three times (5 min each) in PBS to remove unbound primary antibody and then incubated with a secondary anti-rabbit IgG labeled with Texas red (Jackson ImmunoResearch, West Grove, PA) for 45 min at 25°C. Specificity was determined by incubating the antibody in the presence of its peptide antigen (26) before incubation with the sample. Under this condition, significant labeling was not observed. Coverslips were mounted onto glass slides using a 50% glycerol-saline solution containing the antibleach agent paraphenylendiamine (0.1%).

For standard wide-field imaging, slides were mounted on the stage of an Olympus IX-70 microscope equipped with a x60 1.4 numerical objective. Illumination was provided by a 100-W Hg lamp, and images were acquired by a liquid-cooled charge-coupled device camera (Roper Scientific, Tucson, AZ) equipped with a Kodak charge-coupled device array (KAF1401E). Image analysis was performed on a Silicon Graphics INDY2 workstation using customized software.

Smooth muscle contractility measurements. Thoracic aorta was dissected from male littermate mice. After removal of fatty tissue, the aorta was cut into two pieces (one piece with the endothelium intact and the other half with the endothelium removed by gently rubbing the tissue between the thumb and index finger). Weight and calculated thickness (15) of each aortic segment were not different between {alpha}1sm+ or {alpha}2sm+ mice and their respective WT pairs, averaging 0.81 ± 0.02 mg and 114 ± 3 µm (n = 36), respectively. The aortic strips were threaded between two steel triangles 100 µm in diameter. The triangles were mounted in an organ bath system between a fixed post and a Harvard Apparatus differential capacitor force transducer (South Natick, MA). Isometric force was recorded continuously (Biopac Instruments and Acqknowledge software, Goleta, CA). Tissues were maintained in PSS and bubbled with 95% O2-5% CO2 for pH 7.4 at 37°C. Resting tension of the aorta was adjusted to 30 mN to set an initial length in the range of maximum isometric force generation. The tissues were then challenged with at least two contraction-relaxation cycles with 50 mM KCl (added from concentrate) to ensure reproducible forces. The tissues were then exposed to increasing cumulative concentrations of KCl or phenylephrine (PE). ACh (10–5 M) was used to verify the presence of endothelium in aorta. All forces were analyzed and normalized to cross-sectional area as previously described (15).

Smooth muscle kinetics measurements. Contraction was elicited via depolarization by raising medium KCl to 50 mM, and then relaxation was initiated by rinsing with PSS. Relaxation half-times were calculated as the time (in s) for aorta to relax to 50% of its peak force. Force development half-times were calculated by measuring the elapsed time required for each vessel to reach 50% of its peak force from baseline in response to 50 mM KCl. Similar measurements were performed for challenges with 1 µM PE.

Blood pressure measurements. Systolic blood pressure (SBP) was measured in male littermate mice using a computerized tail-cuff system (BP-2000 blood pressure analysis system; Visitech Systems, Apex, NC). The mice were allowed to acclimate to the apparatus for 5 min before the start of measurement. Ten preliminary and 10 experimental pressures were acquired for 5 consecutive days/wk. Pressures were taken on the same days each week and at the same time each day. Data were accepted if the mouse had valid readings for at least 5 of the 10 experimental pressures taken. Blood pressures were obtained during a 2-wk period. The daily blood pressure averages per mouse were averaged to determine the mean SBP for that mouse.

Statistical analysis. The data are presented as means ± SE, where n is equal to the number of samples. Significance was determined with an unpaired Student's t-test, with a P ≤ 0.05 taken as significant where only two variables were compared. For force-concentration relations, multivariate analysis using ANOVA and Holm-Sidak post hoc analysis was applied using SigmaStat 3.1.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Generation of NKA {alpha}-isoform transgenic mice. Transgenic mice were generated by inserting {alpha}1- or {alpha}2-isoform cDNA (31) between the smooth muscle-specific {alpha}-actin promoter, SMP8 (6) and a polyadenylation sequence in the SMP8 + RPNKAA + human growth hormone poly(A) plasmid (Fig. 1). After pronuclear microinjection with the linearized transgene, one NKA transgenic founder for the {alpha}1-isoform (line 09) screened from 14 mice by PCR and Southern blot analyses was identified (Fig. 2). Two NKA transgenic founders for the {alpha}2-isoform (line 79 and line 84) were identified from 35 resultant mice (Fig. 2). Transmission of the transgenes from founder mice to offspring was verified by Southern blot (Fig. 2B). Both {alpha}1sm+ line 09 mice and {alpha}2sm+ line 84 mice have normal litter sizes of eight and seven pups, respectively, although the frequency of litters born is less in {alpha}1sm+ line 09 than in WT mice. As calculated from PCR analysis, the transgene was passed onto ~44% of offspring in {alpha}1sm+ line 09 mice and to ~51% of {alpha}2sm+ line 84 mice. The {alpha}2sm+ line 79 mice have small litter sizes, averaging only 3.6 mice, and a low frequency of births; transmittance of the transgene appeared normal with ~53% of the offspring carrying the transgene. In all transgenic lines, Mendelian ratios of male to female mice were observed. Because of the small litter sizes in line 79 {alpha}2sm+ mice, studies in {alpha}2sm+ mice were confined to line 84. There were no gross anatomic abnormalities in NKA transgenic mice as measured by body and wet tissue weights of both smooth and nonsmooth muscle tissues (Table 1).


Figure 2
View larger version (18K):
[in this window]
[in a new window]

 
Fig. 2. Identification of NKA {alpha}-isoform transgenic mice. A: PCR analysis. Primers targeting the {alpha}1-isoform transgene yielded a 354-bp product, and primers targeting the {alpha}2-isoform transgene yielded a 345-bp product. Linearized constructs of the {alpha}-isoform transgenes served as positive controls. H2O and wild-type (WT) mouse DNA served as negative controls (data not shown). B: Southern blot. Probes containing {alpha}1- or {alpha}2-isoform cDNA hybridized to a 4-kb fragment of tail DNA that was digested with HindIII. The linearized {alpha}-isoform transgene constructs served as positive controls (data not shown), and WT mouse DNA served as negative controls.

 

View this table:
[in this window]
[in a new window]

 
Table 1. Summary of body and wet tissue weights

 
Coordinate expression of NKA {alpha}-isoforms. We next determined the degree of NKA {alpha}-isoform expression at the protein level using Western blot analysis (Table 2 and Fig. 3). Our initial focus was on vascular function; however, limitations posed by tissue mass (aorta ~1–2 mg) and fecundity of the {alpha}1-isoform line necessitated various approaches with respect to Western blot analysis. We used gastric antrum (100–150 mg) for overall assessment of NKA and aorta where possible. The {alpha}1-isoform was increased by ~1.4-fold in gastric antrum from {alpha}1sm+ mice. Interestingly, the {alpha}2-isoform, which is not contained in the transgene in {alpha}1sm+ mice, was also increased by 1.6-fold. In the {alpha}2sm+ mice, the {alpha}2-isoform was increased 2.4-fold in aorta and 5.8-fold in gastric antrum compared with paired WT mice. Similar to the {alpha}1sm+ mice, we measured a coordinate increase in the {alpha}-isoform not contained in the transgene in {alpha}2sm+ mice, as the {alpha}1-isoform was elevated by twofold in aorta and sevenfold in gastric antrum. Using an antibody recognizing all NKA {alpha}-isoforms, we obtained increases in total NKA of 1.5- and 3.7-fold in the {alpha}1sm+ and {alpha}2sm+ lines, respectively. These differences in increases were not statistically significant within each tissue type. The greater degree of increased {alpha}-isoform expression in the antrum than in the aorta is consistent with previously reported findings that the SMP8 promoter has a greater expression in stomach than aorta (33). Therefore, both NKA transgenic lines ({alpha}1sm+ and {alpha}2sm+ mice) exhibited increases in both the NKA {alpha}1- and {alpha}2-isoforms in smooth muscle with the {alpha}2sm+ mouse line displaying a greater degree of increased NKA {alpha}-isoform expression than the {alpha}1sm+ line.


View this table:
[in this window]
[in a new window]

 
Table 2. Summary of Western blot data of NKA {alpha}-isoforms

 

Figure 3
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 3. NKA {alpha}-isoform protein in mouse antrum and aorta. Representative Western blots for the relative NKA {alpha}-isoform contents in {alpha}1sm+ (A) and {alpha}2sm+ (B) mouse smooth muscle tissues compared with paired WT tissue samples are shown. Actin was used as a loading control. Western blot data are summarized in Table 2.

 
Both NKA {alpha}1- and {alpha}2-isoforms, as well as total NKA (detected with an antibody recognizing all {alpha}-isoforms), were measured in hearts from {alpha}1sm+ or {alpha}2sm+ mice and their respective WT pairs. There were no statistically significant differences in {alpha}1- or {alpha}2-isoform protein levels in NKA transgenic hearts compared with WT hearts (Table 2). These data support previous reports (6, 33) detailing the specificity of the SMP8 promoter to smooth muscle.

Because upregulation of the {alpha}-isoform not contained in the transgene was observed at the protein level in NKA transgenic mice, we wanted to verify whether the coordinate upregulation occurred at the transcriptional level as well. We measured mRNA levels of the {alpha}-isoforms in gastric antrum from {alpha}1sm+ or {alpha}2sm+ mice relative to respective paired WT antrum using real-time PCR analysis. Coordinate upregulation of the {alpha}-isoforms was also evident at the mRNA level in NKA transgenic mice (Fig. 4). The mRNA for {alpha}1- and {alpha}2-isoforms was increased 4.3- and 2.5-fold, respectively, in {alpha}1sm+ mice and 10.7- and 8.6-fold in {alpha}2sm+ mice.


Figure 4
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 4. NKA {alpha}-isoform mRNA levels in gastric antrum. mRNA levels in {alpha}1sm+ and {alpha}2sm+ mouse antrum, measured by real-time PCR, are presented as a percentage of the paired WT mRNA. {alpha}1- and {alpha}2-isoforms were elevated 4.3 ± 2.2- and 2.5 ± 0.9-fold, respectively, in {alpha}1sm+ mice and 10.7 ± 2.9- and 8.6 ± 3.2-fold in {alpha}2sm+ mice. Values are means ± SE (n = 3 samples). *P < 0.05.

 
Relative beta-isoform levels. NKA is composed of a catalytic {alpha}-subunit (~112 kDa) and a glycosylated beta-subunit (40–60 kDa) (2, 4, 8, 16), which is required to make a functional NKA heterodimer (9). We measured relative protein levels of the NKA beta1- and beta2-isoforms in gastric antrum from NKA transgenic mice (Fig. 5). In {alpha}1sm+ mice, little differences in beta1- or beta2-isoforms were seen, with expression being 0.9 of WT levels. In {alpha}2sm+ mice, which expressed increased {alpha}-isoforms to a greater extent, the beta1- and beta2-isoforms were increased by 1.3- and 1.4-fold, respectively.


Figure 5
View larger version (26K):
[in this window]
[in a new window]

 
Fig. 5. beta-Subunit protein in NKA transgenic (TG) mice. A: representative Western blots of NKA beta1- or beta2-isoforms in gastric antrum from {alpha}1sm+ and {alpha}2sm+ mice. Antrum protein was deglycosylated for beta-subunit detection, resulting in an approximate molecular mass of 30 kDa. B: quantitation of Western blots for beta1- and beta2-isoform expression in {alpha}1sm+ and {alpha}2sm+ mouse antrum represented as a percentage of paired WT antrum. Values are means ± SE; n = 3 samples, where each sample consisted of 3 pooled antrum per genotype.

 
NKA activity. To measure a functional increase in NKA in our transgenic mice, we measured NKA activity. The total enzyme activity was increased in gastric antrum from both {alpha}1sm+ and {alpha}2sm+ mice, and the percentage of ouabain inhibition {100 x [1 – (ATPase activity + ouabain)/total ATPase activity]} measured in transgenic antrum samples was also moderately increased. NKA activity was elevated by ~2.5-fold in gastric antrum from {alpha}2sm+ mice compared with paired WT antrum (Table 3), whereas NKA activity in protein from {alpha}1sm+ antrum was only moderately increased, and the difference was not significant.


View this table:
[in this window]
[in a new window]

 
Table 3. NKA activity measurements in gastric antrum

 
Immunocytochemistry of aortic smooth muscle cells. Our previous study (30) indicated that the {alpha}1-isoform is uniformly distributed across the plasma membrane of mouse aortic smooth muscle cells, whereas the {alpha}2-isoform is more localized. Because targeting of the {alpha}-isoforms could be altered with transgene expression, we used immunocytochemistry to determine whether their general cellular distribution remained unchanged. We utilized the {alpha}2sm+ mouse line for immunocytochemistry because smooth muscle from {alpha}2sm+ mice displayed the greater degree of increased {alpha}-isoform expression, assuming that differences would be emphasized with this mouse line. Wide-field images of primary cultured aortic smooth muscle cells from WT and {alpha}2sm+ mice showed that the NKA {alpha}-isoforms in cells from {alpha}2sm+ mice had similar distributions to cells from WT mice (Fig. 6).


Figure 6
View larger version (41K):
[in this window]
[in a new window]

 
Fig. 6. Immunocytochemical micrographs showing NKA {alpha}-isoforms in primary cultured aortic smooth muscle cells. Wide-field microscopic images were taken of cultured aortic smooth muscle cells incubated with fluorescently labeled anti-{alpha}1- or anti-{alpha}2-antibodies. Left: cells from WT mice. Right: cells from {alpha}2sm+ mice. The {alpha}2-isoform has a reticular distribution in cells from {alpha}2sm+ similar to those from WT aorta, whereas the {alpha}1-isoform maintained a wide-spread distribution in {alpha}2sm+ cells similar to WT. Scale bars = 20 µm.

 
SBP. To investigate potential cardiovascular effects of increased NKA in the intact mouse, we measured SBP in {alpha}1sm+ and {alpha}2sm+ mice using tail sphygmomanometry. The SBP of {alpha}1sm+ mice was not different from its WT littermates (123.0 ± 2.5 mmHg, n = 11, vs. 117.4 ± 2.3 mmHg, n = 12; P = 0.11) (Fig. 7A). The {alpha}2sm+ mice, which had higher levels of NKA {alpha}-isoforms, had a significantly lower SBP (109.9 ± 1.6 mmHg, n = 13; P < 0.05) compared with WT littermates (121.3 ± 1.4 mmHg, n = 11) (Fig. 7B).


Figure 7
View larger version (10K):
[in this window]
[in a new window]

 
Fig. 7. Systolic blood pressure (SBP) in NKA transgenic mice. SBP was measured using tail cuff sphygmomanometry (see METHODS). {alpha}1sm+ and {alpha}2sm+ mice were compared with their WT littermates (labeled WT {alpha}1 and WT {alpha}2, respectively). A: histogram of the daily SBP measurements in WT {alpha}1 and {alpha}1sm+ mice. B: WT {alpha}2 and {alpha}2sm+ mice fitted to Gaussian distributions. Black bars and lines represent transgenic data, and gray bars and lines represent WT data. SBP results in {alpha}1sm+ mice was similar to those in WT {alpha}1 mice (122.7 ± 2.5 mmHg, n = 11, vs. 117.4 ± 2.3 mmHg, n = 12). The {alpha}2sm+ mice had a significantly lower SBP than the WT {alpha}2 mice (109.9 ± 1.6 mmHg, n = 13, vs. 121.3 ± 1.4 mmHg, n = 11). *P < 0.05.

 
Smooth muscle mechanics. As a first step to correlate blood pressure differences with changes in smooth muscle function, we measured force-concentration relations in aorta from NKA transgenic mice. Membrane depolarization by elevating medium KCl and, for comparison, the receptor-mediated agonist PE was used to activate contraction. In endothelium-denuded aorta from {alpha}1sm+ mice, there were no differences in isometric force developed per crosssectional area in response to either elevated KCl or PE (Fig. 8, A and B). Developed force in {alpha}2sm+ endothelium-denuded aorta was moderately increased compared with its paired WT aorta for KCl (P = 0.008) and PE (P = 0.006) when the relation between developed force and agonist concentration was compared (Fig. 8, C and D). In endothelium-intact aorta, there were no differences in isometric forces developed between {alpha}1sm+ or {alpha}2sm+ and respective WT mice in the force-concentration relations for KCl or PE. There were small but significant differences in the sensitivities (EC50) of {alpha}1sm+ or {alpha}2sm+ aortas compared with WT pairs as summarized in Table 4; however, no trends were observed.


Figure 8
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 8. Developed force-concentration relations in endothelium-intact (+E) and endothelium-denuded (–E) aorta from {alpha}1sm+ and {alpha}2sm+ mice. Developed isometric force was measured in aorta from {alpha}1sm+ and paired WT mice (left) and {alpha}2sm+ and respective WT aorta (right) in response to KCl (A and C) and phenylephrine (PE; B and D). Symbols are mean values, with bars representing ±SE. For {alpha}1sm+ (A and B, circles), there were no differences from either +E aorta (solid symbols and lines) or –E aorta (open symbols and dashed lines) and their respective WT (squares). For {alpha}2sm+ (C and D), the +E aorta also did not differ; however, the –E aorta were statistically different from the WT.

 

View this table:
[in this window]
[in a new window]

 
Table 4. Summary of sensitivities (EC50) of {alpha}1sm+ and {alpha}2sm+ aorta to KCl, PE, or ACh

 
We evaluated the potential role of increased NKA {alpha}-isoform levels on relaxation. Endothelium-dependent relaxation to ACh in aorta from {alpha}1sm+ or {alpha}2sm+ mice was not different compared with respective WT mice (Fig. 9). We also tested beta-adrenergic relaxation in response to isoproterenol or the exogenous nitric oxide donor, sodium nitroprusside, and found no differences in relaxation-concentration relations in aorta from {alpha}2sm+ mice compared with paired WT mice (data not shown). However, aorta from {alpha}2sm+ mice had a small but significant decrease in sensitivity (EC50) in response to ACh (Table 4).


Figure 9
View larger version (12K):
[in this window]
[in a new window]

 
Fig. 9. Force-concentration relations for aorta for the endothelium-dependent vasodilator ACh from {alpha}1sm+ (A) or {alpha}2sm+ (B) mice. +E aortas (solid symbols) from {alpha}1sm+ or {alpha}2sm+ mice did not display any differences in the relaxation-concentration relations. –E aortas (open symbols) only had minimal vasorelaxation with ACh. Symbols are mean values, with bars representing ±SE.

 
Smooth muscle kinetics in NKA transgenic mice. To assess any possible differences in the kinetics of contraction and relaxation, we measured the half times for the aorta to achieve 50% of its maximal contraction (peak) in response to either 50 mM KCl or 1 µM PE and the recovery to 50% of the peak value after removal of the activating agent. Using a data structure analogous to Table 5, we found no statistically significant differences in half times of force development in response to either KCl or PE in either {alpha}1sm+ or {alpha}2sm+ mice compared with their respective WT pairs (n = 9–17; data not shown). In contrast to the half-time of force development, the half-time for relaxation from a KCl-induced contraction of {alpha}2sm+ endothelium-denuded aorta was smaller than its WT (P < 0.05, Table 5), indicating that the relaxation was faster. The relaxation half-time from a KCl-induced contraction for {alpha}1sm+ endothelium-denuded aorta, which has a lesser degree of increased {alpha}-isoform levels than the {alpha}2sm+ line, was not significantly different (Table 5). In endothelium-intact aorta, no differences in relaxation half-times for KCl or PE contractures were seen in {alpha}1sm+ or {alpha}2sm+ mice. Aortas with an intact endothelium relaxed faster than endothelium-denuded aortas, as would be expected because of the endothelial contribution to relaxation.


View this table:
[in this window]
[in a new window]

 
Table 5. Relaxation half-times for {alpha}1sm+ and {alpha}2sm+ aorta in response to 50 mM KCl or 1 µM PE

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The NKA is of known importance in blood pressure regulation, and alterations in NKA are hypothesized to underlie several disease conditions. However, there is little direct evidence on the effects attributable to vascular smooth muscle NKA per se on blood pressure. Thus we developed mice expressing a transgene for either the NKA {alpha}1- or {alpha}2-isoforms using the smooth muscle-specific promoter SMP8 (6). Both NKA {alpha}-isoform proteins increased by ~1.5-fold in the {alpha}1sm+ mice, whereas the {alpha}2sm+ mice had a greater degree of expression, of up to 7-fold. The bases underlying differences in the extent of {alpha}-isoform expression in the transgenic lines is not known but could be due to differences in transgene insertion or copy number.

The first novel result was coordinate expression of the {alpha}1- and {alpha}2-isoforms in smooth muscle; that is, the {alpha}-isoform contained in the transgene and the {alpha}-isoform not contained in the transgene were coordinately increased by approximately the same percentages. There is little available evidence on how the levels of NKA are regulated. A coordinate increase in {alpha}-isoform expression could be due to a decrease in protein degradation, transcriptional upregulation, or stabilization of the transcript. Our real-time PCR data indicate that the coordinate {alpha}-isoform increases seen at the protein level are due in part to an increase in the RNA message for both isoforms.

There is substantial evidence indicating that the SMP8 promoter is expressed only in smooth muscle (6, 33). This is supported by our results in hearts from NKA transgenic mice, which showed no change in {alpha}-isoform protein levels. Thus it is unlikely that the coordinate increase in {alpha}-isoforms is due to general changes in endocrine status or compensation, as this would have affected the {alpha}-isoform distribution of the heart.

NKA is reported to participate in several signaling pathways via its modulation of [Ca2+]i (28). Alteration of NKA activity by ouabain can translate to activation of signaling proteins, such as NF-{kappa}B, which may lead to activation or deactivation of expression of various genes (28). This could underlie the coordinate upregulation of the opposite {alpha}-isoform.

Importantly, the increases in NKA {alpha}-isoform levels in smooth muscle from NKA transgenic mice were accompanied by increases in total NKA activity. Thus the increase in protein translated to increased NKA function. The measured increase in total NKA activity was less than the observed increase in protein expression in {alpha}2sm+ mice. One explanation is that Western blot and NKA activity measurements are two very different parameters that require different sample preparations and different measurement techniques, each with varying degrees of sensitivity of detection, extent of nonspecific signals, and amplification, thus making absolute measurements not necessarily directly comparable. The low NKA density in smooth muscle, 100-fold less than cardiac or skeletal muscle (3, 14), and limited tissue mass decrease the precision of NKA measurements in smooth muscle. Another possibility is the availability of the beta-subunit, which is required for NKA function (9). In smooth muscle from antrum, we measured little change in beta-subunit levels from {alpha}1sm+ mice, but {alpha}2sm+ mice had a 25–40% increase in beta-subunit protein levels. There is no available evidence on the absolute ratio of {alpha} to beta in smooth muscle to our knowledge. There are some indications that the beta-subunit is synthesized in excess of the {alpha}-subunit (19, 21). The beta-subunit could be a limiting factor to increasing the NKA activity. However, the beta-subunit is also reported to be required for targeting of the {alpha}-isoform to the plasma membrane (9). Our immunomicrographs showed that the distributions of {alpha}1-and {alpha}2-isoforms in the {alpha}2sm+ mice were similar to those in WT mice, which would argue against a beta-subunit-limited NKA activity.

Increased expression of NKA had a major impact on SBP. The {alpha}2sm+ mice were hypotensive compared with WT littermates, whereas {alpha}1sm+ mice were normotensive. Because total NKA activity is substantially higher in the {alpha}2sm+ mice than in the {alpha}1sm+ mice, the differences in SBP are likely a result of the degree of NKA expression. A significant decrease in SBP is relatively unusual in light of the generally small SBP changes in the literature associated with a single gene alteration (29). Our data support the hypothesis that increased NKA activity results in a decreased SBP and moreover that this can be solely a vascular phenomenon. Thus our gain-of-function experiments complement studies of decreasing NKA activity (7, 11, 36), which suggest that the vascular NKA alone could be an important factor in hypertension.

To evaluate the potential changes in vascular smooth muscle that may underlie the decreased blood pressure, we measured contractility and relaxation parameters in aorta. Consistent with the absence of change in blood pressure, there were no differences in contractility to KCl or PE stimulation in aortas from the {alpha}1sm+ mice. The {alpha}2sm+ aortas had moderately increased force in response to KCl (15–20%) or PE stimulation (12–15%). Higher forces are seemingly the opposite of the predicted increased Ca2+ extrusion by NKA-NCX coupling.

One might have anticipated that the increase in NKA and fall in blood pressure would both be accompanied by a decrease in aortic smooth muscle contractility. There are several possibilities behind the increase in force seen in endothelium-denuded {alpha}2sm+ aorta. 1) The increased Na+ gradient could stimulate Na+/H+ exchange, leading to cytosolic alkalinization, which can lead to higher levels of contractility (20). 2) The relative functional roles of {alpha}1 to {alpha}2 may be important. A modification of the hypothesis of coupled NKA-NCX Ca2+ extrusion has been proposed based on the differential distribution (Fig. 6) of {alpha}-isoforms. Blaustein and colleagues (1, 10) proposed that {alpha}2-NKA and NCX are localized in plasma membrane microdomains with preferential access to Ca2+ loading of the sarcoplasmic reticulum (SR). Increases in the {alpha}2-isoform in this compartment would lower SR loading, which could outweigh the effects of {alpha}1 on global [Ca2+]i. For example, a hypoloaded SR could lead to lower spontaneous SR Ca2+ release and consequently lower KCa channel activity, which would lead to depolarization and greater contractility (35). 3) Another possibility to consider is the role of NKA in signaling. NKA is postulated to lead to possible activation of signal transduction factors like NF-{kappa}B or Src (28). This may lead to the upregulation and downregulation of genes related to and/or unrelated to ion transport and/or contractility, thereby resulting in changes in aortic contractility, which remains to be elucidated.

One can also envision that either decreases or increases in contractile force, depending on which circulation (renal, central nervous system, etc.), could lead to reduced blood pressure. In some ways, it would be rather remarkable if changes in aortic smooth muscle reflected every microcirculation. However, this was the simplest hypothesis and important to test. The increases in contractile forces in {alpha}2sm+ mice were only measured in endothelium-denuded aorta. Endothelium-intact aorta, a perhaps more physiological representative of the in vivo vessel, did not display any differences in contractility, suggesting some basal endothelial compensation. It is possible that the compensation is more effective in other microcirculations or at the resistance vessel level or that other microvasculatures simply differ from aorta. Understanding the mechanism(s) underlying the decrease in blood pressure will require future studies.

Importantly, mechanical factors other than the developed force may be in play in the observed hypotension. Of particular interest, there is a correlation between speed of relaxation and blood pressure. Studies of spontaneously hypertensive rats report slower relaxation rates in caudal and mesenteric arteries (23, 24). We measured relaxation half-times in {alpha}1sm+ and {alpha}2sm+ mice. The {alpha}2sm+ aortas had faster rates of relaxation, indicating possible increased Ca2+ extrusion. A decreased blood pressure associated with faster aortic relaxation was recently reported for diabetic rats (27). We would suggest that the observed faster rates of aortic relaxation may be a larger factor leading to the observed hypotension rather than the effects of the moderately increased maximum force.

In summary, our results indicate that a genetically engineered increase in NKA activity is associated with a decreased SBP, which is dependent on the degree of vascular NKA expression. Thus focusing on vascular NKA per se may provide novel insights for treatment of hypertension.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by National Heart, Lung, and Blood Institute Grant HL-66044 (R. J. Paul and R. M. Lynch).


    ACKNOWLEDGMENTS
 
We thank Dr. Jerry Lingrel for kindly providing us with the rat Na+-K+-ATPase {alpha}1- and {alpha}2-isoform cDNAs and Dr. Arthur Strauch for the SMP8 promoter.


    FOOTNOTES
 

Address for reprint requests and other correspondence: R. J. Paul, Molecular and Cellular Physiology, Univ. of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0576 (e-mail: richard.paul{at}uc.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Arnon A, Hamlyn JM, Blaustein MP. Ouabain augments Ca2+ transients in arterial smooth muscle without raising cytosolic Na+. Am J Physiol Heart Circ Physiol 279: H679–H691, 2000.[Abstract/Free Full Text]
  2. Aydemir-Koksoy A. Na-ATPase: a review. J Ankara Med Sch 24: 73–82, 2002.
  3. Aydemir-Koksoy A, Allen JC. Regulation of Na+ pump expression by vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 280: H1869–H1874, 2001.[Abstract/Free Full Text]
  4. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol Renal Physiol 275: F633–F650, 1998.[Abstract/Free Full Text]
  5. Blaustein MP, Zhang J, Chen L, Hamilton BP. How does salt retention raise blood pressure? Am J Physiol Regul Integr Comp Physiol 290: R514–R523, 2006.[Abstract/Free Full Text]
  6. Cogan JG, Sun S, Stoflet ES, Schmidt LJ, Getz MJ, Strauch AR. Plasticity of vascular smooth muscle alpha-actin gene transcription. Characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblasts and fibroblasts. J Biol Chem 270: 11310–11321, 1995.[Abstract/Free Full Text]
  7. Dostanic-Larson I, Lorenz JN, Van Huysse JW, Neumann JC, Moseley AE, Lingrel JB. Physiological role of the {alpha}1- and {alpha}2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site. Am J Physiol Regul Integr Comp Physiol 290: R524–R528, 2006.[Abstract/Free Full Text]
  8. Ewart HS, Klip A. Hormonal regulation of the Na+-K+-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol Cell Physiol 269: C295–C311, 1995.[Abstract/Free Full Text]
  9. Fambrough DM, Lemas MV, Hamrick M, Emerick M, Renaud KJ, Inman EM, Hwang B, Takeyasu K. Analysis of subunit assembly of the Na-K-ATPase. Am J Physiol Cell Physiol 266: C579–C589, 1994.[Abstract/Free Full Text]
  10. Golovina V, Song H, James P, Lingrel J, Blaustein M. Regulation of Ca2+ signaling by Na+ pump {alpha}-2 subunit expression. Ann NY Acad Sci 986: 509–513, 2003.[CrossRef][Web of Science][Medline]
  11. Haddy FJ. Role of dietary salt in hypertension. Life Sci 79: 1585–1592, 2006.[CrossRef][Web of Science][Medline]
  12. Huddleson JP, Srinivasan S, Ahmad N, Lingrel JB. Fluid shear stress induces endothelial KLF2 gene expression through a defined promoter region. Biol Chem 385: 723–729, 2004.[CrossRef][Web of Science][Medline]
  13. Iwamoto T, Kita S. Hypertension, Na+/Ca2+ exchanger, and Na-ATPase. Kidney Int 69: 2148–2154, 2006.[CrossRef][Web of Science][Medline]
  14. Kjeldsen K, Bjerregaard P, Richter EA, Thomsen PE, Norgaard A. Na+,K+-ATPase concentration in rodent and human heart and skeletal muscle: apparent relation to muscle performance. Cardiovasc Res 22: 95–100, 1988.[Web of Science][Medline]
  15. Lalli J, Harrer JM, Luo W, Kranias EG, Paul RJ. Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle. Circ Res 80: 506–513, 1997.[Abstract/Free Full Text]
  16. Lingrel JB, Kuntzweiler T. Na-ATPase. J Biol Chem 269: 19659–19662, 1994.[Free Full Text]
  17. Lynch RM, Fogarty KE, Fay FS. Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy. J Cell Biol 112: 385–395, 1991.[Abstract/Free Full Text]
  18. McDonough AA, Velotta JB, Schwinger RH, Philipson KD, Farley RA. The cardiac sodium pump: structure and function. Basic Res Cardiol 97, Suppl 1: I19–I24, 2002.[Medline]
  19. Mircheff AK, Bowen JW, Yiu SC, McDonough AA. Synthesis and translocation of Na+-K+-ATPase {alpha}- and beta-subunits to plasma membrane in MDCK cells. Am J Physiol Cell Physiol 262: C470–C483, 1992.[Abstract/Free Full Text]
  20. Nagesetty R, Paul RJ. Effects of pHi on isometric force and [Ca2+]i in porcine coronary artery smooth muscle. Circ Res 75: 990–998, 1994.[Abstract/Free Full Text]
  21. Orlowski J, Lingrel JB. Tissue-specific and developmental regulation of rat Na,K-ATPase catalytic {alpha} isoform and beta subunit mRNAs. J Biol Chem 263: 10436–10442, 1988.[Abstract/Free Full Text]
  22. Otsu K, Kuruma A, Yanagida E, Shoji S, Inoue T, Hirayama Y, Uematsu H, Hara Y, Kawano S. Na+/K+ ATPase and its functional coupling with Na+/Ca2+ exchanger in mouse embryonic stem cells during differentiation into cardiomyocytes. Cell Calcium 37: 137–151, 2005.[CrossRef][Web of Science][Medline]
  23. Packer CS, Stephens NL. Mechanics of caudal artery relaxation in control and hypertensive rats. Can J Physiol Pharmacol 63: 209–213, 1985.[Web of Science][Medline]
  24. Packer CS, Stephens NL. Prolonged isobaric relaxation time in small mesenteric arteries of the spontaneously hypertensive rat. Can J Physiol Pharmacol 65: 230–235, 1987.[Web of Science][Medline]
  25. Pfaffl MW.A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.[Abstract/Free Full Text]
  26. Pressley TA. Phylogenetic conservation of isoform-specific regions within alpha-subunit of Na+-K+-ATPase. Am J Physiol Cell Physiol 262: C743–C751, 1992.[Abstract/Free Full Text]
  27. Rinaldi GJ. Blood pressure fall and increased relaxation of aortic smooth muscle in diabetic rats. Diabetes Metab 31: 487–495, 2005.[CrossRef][Web of Science][Medline]
  28. Scheiner-Bobis G, Schoner W. A fresh facet for ouabain action. Nat Med 7: 1288–1289, 2001.[CrossRef][Web of Science][Medline]
  29. Schnermann J, Lorenz JN, Briggs JP. Cardiorenal physiology of the mouse: from loss of genome to gain of phenome. In: The Molecular and Genetic Basis of Renal Disease, edited by Pollak M and Mount DB. In press.
  30. Shelly DA, He S, Moseley A, Weber C, Stegemeyer M, Lynch RM, Lingrel J, Paul RJ. Na+ pump {alpha}2-isoform specifically couples to contractility in vascular smooth muscle: evidence from gene-targeted neonatal mice. Am J Physiol Cell Physiol 286: C813–C820, 2004.[Abstract/Free Full Text]
  31. Shull GE, Greeb J, Lingrel JB. Molecular cloning of three distinct forms of the Na+,K+-ATPase {alpha}-subunit from rat brain. Biochemistry 25: 8125–8132, 1986.[CrossRef][Medline]
  32. Sweeney G, Klip A. Regulation of the Na+/K+-ATPase by insulin: why and how? Mol Cell Biochem 182: 121–133, 1998.[CrossRef][Web of Science][Medline]
  33. Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, Fagin JA. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest 100: 1425–1439, 1997.[Web of Science][Medline]
  34. Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 289: H1781–H1793, 2005.[Abstract/Free Full Text]
  35. Wellman GC, Nelson MT. Signaling between SR and plasmalemma in smooth muscle: sparks and the activation of Ca2+-sensitive ion channels. Cell Calcium 34: 211–229, 2003.[CrossRef][Web of Science][Medline]
  36. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG, Blaustein MP. Sodium pump {alpha}2 subunits control myogenic tone and blood pressure in mice. J Physiol 569: 243–256, 2005.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
HypertensionHome page
M. P. Blaustein, J. Zhang, L. Chen, H. Song, H. Raina, S. P. Kinsey, M. Izuka, T. Iwamoto, M. I. Kotlikoff, J. B. Lingrel, et al.
The Pump, the Exchanger, and Endogenous Ouabain: Signaling Mechanisms That Link Salt Retention to Hypertension
Hypertension, February 1, 2009; 53(2): 291 - 298.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/2/H1172    most recent
00279.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pritchard, T. J.
Right arrow Articles by Paul, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pritchard, T. J.
Right arrow Articles by Paul, R. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.